These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28974758)

  • 1. Evaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imaging.
    Tsubata Y; Hayashi M; Tanino R; Aikawa H; Ohuchi M; Tamura K; Fujiwara Y; Isobe T; Hamada A
    Sci Rep; 2017 Oct; 7(1):12622. PubMed ID: 28974758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.
    Nishidate M; Yamamoto K; Masuda C; Aikawa H; Hayashi M; Kawanishi T; Hamada A
    Sci Rep; 2017 Dec; 7(1):16763. PubMed ID: 29196706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging.
    Nishimura M; Hayashi M; Mizutani Y; Takenaka K; Imamura Y; Chayahara N; Toyoda M; Kiyota N; Mukohara T; Aikawa H; Fujiwara Y; Hamada A; Minami H
    Oncotarget; 2018 Apr; 9(26):18540-18547. PubMed ID: 29719624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous distribution of alectinib in neuroblastoma xenografts revealed by matrix-assisted laser desorption ionization mass spectrometry imaging: a pilot study.
    Ryu S; Hayashi M; Aikawa H; Okamoto I; Fujiwara Y; Hamada A
    Br J Pharmacol; 2018 Jan; 175(1):29-37. PubMed ID: 29027209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix-assisted laser desorption ionization - mass spectrometry imaging of erlotinib reveals a limited tumor tissue distribution in a non-small-cell lung cancer mouse xenograft model.
    Kim TY; Lee B; Kim Y; Sugihara Y; Rezeli M; Szasz AM; Dome B; Marko-Varga G; Kwon HJ
    Clin Transl Med; 2021 Jul; 11(7):e481. PubMed ID: 34323418
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue-Specific Distribution of Sphingomyelin Species in Pork Chop Revealed by Matrix-Assisted Laser Desorption/Ionization-Imaging Mass Spectrometry.
    Enomoto H; Takeda S; Hatta H; Zaima N
    J Food Sci; 2019 Jul; 84(7):1758-1763. PubMed ID: 31206696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approach of MALDI drug imaging, immunohistochemistry, and digital image analysis for drug distribution studies in tissues.
    Huber K; Feuchtinger A; Borgmann DM; Li Z; Aichler M; Hauck SM; Zitzelsberger H; Schwaiger M; Keller U; Walch A
    Anal Chem; 2014 Nov; 86(21):10568-75. PubMed ID: 25263480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrogen and Sulfur Co-doped Carbon-Dot-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Imaging for Profiling Bisphenol S Distribution in Mouse Tissues.
    Lin Z; Wu J; Dong Y; Xie P; Zhang Y; Cai Z
    Anal Chem; 2018 Sep; 90(18):10872-10880. PubMed ID: 30139256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental models to study drug distributions in tissue using MALDI mass spectrometry imaging.
    Végvári Á; Fehniger TE; Rezeli M; Laurell T; Döme B; Jansson B; Welinder C; Marko-Varga G
    J Proteome Res; 2013 Dec; 12(12):5626-33. PubMed ID: 24134601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization and evaluation of MALDI TOF mass spectrometric imaging for quantification of orally dosed octreotide in mouse tissues.
    Rao T; Shen B; Zhu Z; Shao Y; Kang D; Li X; Yin X; Li H; Xie L; Wang G; Liang Y
    Talanta; 2017 Apr; 165():128-135. PubMed ID: 28153232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI.
    Chen YF; Yuan A; Cho KH; Lu YC; Kuo MY; Chen JH; Chang YC
    PLoS One; 2017; 12(11):e0187824. PubMed ID: 29121075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer.
    Grüner BM; Winkelmann I; Feuchtinger A; Sun N; Balluff B; Teichmann N; Herner A; Kalideris E; Steiger K; Braren R; Aichler M; Esposito I; Schmid RM; Walch A; Siveke JT
    Mol Cancer Ther; 2016 May; 15(5):1145-52. PubMed ID: 26823494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging.
    Marko-Varga G; Fehniger TE; Rezeli M; Döme B; Laurell T; Végvári A
    J Proteomics; 2011 Jun; 74(7):982-92. PubMed ID: 21440690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis.
    Swales JG; Tucker JW; Strittmatter N; Nilsson A; Cobice D; Clench MR; Mackay CL; Andren PE; Takáts Z; Webborn PJ; Goodwin RJ
    Anal Chem; 2014 Aug; 86(16):8473-80. PubMed ID: 25084360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.
    Bartelink IH; Prideaux B; Krings G; Wilmes L; Lee PRE; Bo P; Hann B; Coppé JP; Heditsian D; Swigart-Brown L; Jones EF; Magnitsky S; Keizer RJ; de Vries N; Rosing H; Pawlowska N; Thomas S; Dhawan M; Aggarwal R; Munster PN; Esserman LJ; Ruan W; Wu AHB; Yee D; Dartois V; Savic RM; Wolf DM; van 't Veer L
    Breast Cancer Res; 2017 Sep; 19(1):107. PubMed ID: 28893315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial distribution of elvitegravir and tenofovir in rat brain tissue: Application of matrix-assisted laser desorption/ionization mass spectrometry imaging and liquid chromatography/tandem mass spectrometry.
    Ntshangase S; Mdanda S; Naicker T; Kruger HG; Baijnath S; Govender T
    Rapid Commun Mass Spectrom; 2019 Nov; 33(21):1643-1651. PubMed ID: 31240777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations.
    Wang Y; Singh R; Wang L; Nilsson M; Goonatilake R; Tong P; Li L; Giri U; Villalobos P; Mino B; Rodriguez-Canales J; Wistuba I; Wang J; Heymach JV; Johnson FM
    Oncotarget; 2016 Jul; 7(30):47998-48010. PubMed ID: 27384992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometry.
    Signor L; Varesio E; Staack RF; Starke V; Richter WF; Hopfgartner G
    J Mass Spectrom; 2007 Jul; 42(7):900-9. PubMed ID: 17534860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALDI MSI and LC-MS/MS: Towards preclinical determination of the neurotoxic potential of fluoroquinolones.
    Shobo A; Baijnath S; Bratkowska D; Naiker S; Somboro AM; Bester LA; Singh SD; Naicker T; Kruger HG; Govender T
    Drug Test Anal; 2016 Aug; 8(8):832-8. PubMed ID: 26382199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of matrix-assisted laser desorption/ionization mass spectrometry imaging in combination with LC-MS in pharmacokinetic study of metformin.
    Strnad Š; Vrkoslav V; Klimšová Z; Zemenová J; Cvačka J; Maletínská L; Sýkora D
    Bioanalysis; 2018 Jan; 10(2):71-81. PubMed ID: 29243489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.